Abstract:BACKGROUND. Malaria pathogenicity is determined, in part, by the adherence of Plasmodium falciparum-infected erythrocytes to the microvasculature mediated via specific interactions between P. falciparum erythrocyte membrane protein (PfEMP1) variant domains and host endothelial receptors. Naturally acquired antibodies against specific PfEMP1 variants can play an important role in clinical protection against malaria. METHODS. We evaluated IgG responses against a repertoire of PfEMP1 CIDR domain variants to determine the rate and order of variant-specific antibody acquisition and their association with protection against febrile malaria in a prospective cohort study conducted in an area of intense, seasonal malaria transmission. RESULTS. Using longitudinal data, we found that IgG antibodies against the pathogenic domain variants CIDR alpha 1.7 and CIDR alpha 1.8 were acquired the earliest. Furthermore, IgG antibodies against CIDR gamma 3 were associated with reduced prospective risk of febrile malaria and recurrent malaria episodes. CONCLUSION. This study provides evidence that acquisition of IgG antibodies against PfEMP1 variants is ordered and demonstrates that antibodies against CIDR alpha 1 domains are acquired the earliest in children residing in an area of intense, seasonal malaria transmission. Future studies will need to validate these findings in other transmission settings and determine the functional activity of these naturally acquired CIDR variant-specific antibodies. TRIAL REGISTRATION. ClinicalTrials.gov NCT01322581. FUNDING. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.

<i>Plasmodium falciparum</i>has evolved multiple mechanisms to hijack human immunoglobulin M

Plasmodium falciparum has evolved multiple mechanisms to hijack human immunoglobulin M

Plasmodium Falciparumhas Evolved Multiple Mechanisms to Hijack Human Immunoglobulin M

Functional Human IgA Targets a Conserved Site on Malaria Sporozoites

Plasmodium Falciparum-Specific IgM B Cells Dominate in Children, Expand with Malaria and Produce Parasite Inhibitory IgM

Plasmodium Falciparum–specific IgM B Cells Dominate in Children, Expand with Malaria, and Produce Functional IgM

IgM, Fc mu Rs, and malarial immune evasion.

IgM, FcmRs, and Malarial Immune Evasion

Longitudinal Analysis of Naturally Acquired PfEMP1 CIDR Domain Variant Antibodies Identifies Associations with Malaria Protection.

IgM plays a prominent role in naturally acquired immunity against Plasmodium falciparum gametocytes

Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

The Plasmodium Falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections.

Explorer Identification of the minimal binding region of a Plasmodium falciparum IgM binding PfEMP 1 domain

Plasmodium falciparum var gene expression is modified by host immunity

Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites

Cryo-EM Reveals the Conformational Epitope of Human Monoclonal Antibody PAM1.4 Broadly Reacting with Polymorphic Malarial Protein VAR2CSA.

Antibody Targets on the Surface of Plasmodium falciparum–Infected Erythrocytes That Are Associated With Immunity to Severe Malaria in Young Children

Hijacking the human complement inhibitor C4b-binding protein by the sporozoite stage of the Plasmodium falciparum parasite

Broadly inhibitory antibodies against severe malaria virulence proteins

Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites

Identification of Plasmodium falciparum-specific protein PIESP2 as a novel virulence factor related to cerebral malaria